FDA changes painkiller labels to warn expectant mothers, after 2,500% growth in number of Ky

FDA changes painkiller labels to warn expectant mothers, after 2,500% growth in number of Ky

The U.S. Food and Drug Administration (FDA) announced Tuesday drug-safety labeling changes and new-fangled post-market study supplies in support of all extended-release and long-acting opioids, and Kentucky biased leaders applauded these measures to hold back prescription drug abuse.